Lexa Johnson
Family · Fraser, CONPI 1942878020
Payments from drug & device makers
Across 14 payments — averaging $68.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$490
- Gemini Mountain Medical, LLC$339
- Pacira Pharmaceuticals Incorporated$43
- Globus Medical$22
- Johnson & Johnson$22
- Orthofix Medical, Inc.$16
- plus $28 from 2 others
What the payments were for
- Travel & lodging$66169%
- Food & beverage$30031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 7 | $490 |
| Gemini Mountain Medical, LLC | 1 | $339 |
| Pacira Pharmaceuticals Incorporated | 1 | $43 |
| Globus Medical | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
How this compares
$960 in reported general payments places this provider in the 75th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $5,353 |
| Ondansetron OdtOndansetron | 49 | $501 |
| Oxycodone Hcl | 50 | $350 |
| Meloxicam | 63 | $287 |
| Cyclobenzaprine Hcl | 23 | $255 |
| Tramadol Hcl | 25 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $22 | $5,35316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,182 family providers in Colorado.
Other family in Fraser
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.